ARCHIVES

Phase III Xtandi Trial Meets Primary Endpoints Of Progression-Free and Overall Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | November 29, 2013

Download PDF Visit The Full Archive

Related Articles

Firm To Collaborate With R. W. Johnson On Vaccines.

December 1, 2000

U.S., Canada To Collaborate On Indian Health Services.

May 17, 2002

Board approves continuation of partnerships between minority institutions and cancer centers for research, training, and outreach.

July 9, 2004

John Ultmann, Chicago’s Outspoken Director, Heads In Retirement

August 30, 1991

In Brief: Cancer Claims Morris Kupchan, Who Found Promising New Antitumor Drugs In Plants

October 29, 1976

Survey Shows That One-Third Of Patients Are Undertreated

April 27, 2012